We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Luminex Corporation

Luminex develops, manufactures, and markets biological testing technologies with applications in clinical diagnostics... read more Featured Products: More products

Download Mobile App




Diagnostic Efficacy of Immunomarkers in Fungal Bloodstream Infection

By LabMedica International staff writers
Posted on 05 Feb 2020
Fungemia is the presence of fungi or yeasts in the blood and is a life‐threatening condition with the global mortality rate surging more than fivefold in the past decade. More...
It has been reported that the outcome depends on early and targeted treatment; thus, prompt diagnosis is essential at the early stage of infection.

Currently, early diagnosis of fungemia remains a complicated issue. Although blood culture remains the reference method for the detection of fungemia, this method takes 3‐5 days to generate positive results and also suffers from low sensitivity, which could not meet the requirement of early diagnosis and clinical guidance for fungemia.

Clinical Laboratory scientists at the Chinese PLA General Hospital (Beijing, China) included in their study 41 patients with fungemia who were compared with 57 patients with negative blood culture results. Blood samples for culture were taken from the patients for two to three times and inoculated using BACTEC PLUS Aerobic/F (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) blood culture bottles. The isolations from blood culture were identified to species with VETIK YBC card (bioMérieux, Marcy-l'Étoile, France) and bioMérieux MALDI‐TOF‐MS.

The serum samples were analyzed using the xMAP Bead Array Platform (Luminex Corporation, Austin, TX, USA). A combination of 14 cytokines and chemokines was quantified using the reagents of selected ones from Human Cytokine 30‐Plex Panel Kit (Merck-Millipore, Burlington, MA, USA). Evaluated cytokines included the following: IL‐1β, ‐2, ‐3, ‐4, ‐6, ‐8, 10, 17, 12p70, INF‐γ, TNF‐α, G‐CSF, RANTES, and MIP‐1β. C-reactive protein (CRP) was measured using nephelometric method (Siemens BNII, Cardiophase, Erlangen, Germany), and procalcitonin (PCT) was measured by cobas 800 (Roche, Basel Switzerland) based on electrochemical luminescence technology.

The scientists reported that C‐reactive protein and procalcitonin were significantly higher compared with those in negative control group, while white blood cell, percentage of neutrophil, percentage of lymphocyte, and ratio of neutrophil and lymphocyte did not differentiate between two groups. Serum levels of IFN‐γ, TNF‐α, MIP‐1β, IL‐6, IL‐8, IL‐10, IL‐12p70, and IL‐17 were significantly higher in patients with fungemia compared with the control group. Combination of MIP‐1β and IL‐17 could improve the AUC, sensitivity, and specificity for the diagnosis of fungemia.

The authors concluded that they had found eight serum cytokines/chemokines that significantly increased in the fungemia group when compared with the culture‐negative control group. Among them, MIP‐1β and IL‐17 might be given more attention during the diagnosis of fungemia. The study was published on January 23, 2020 in the Journal of Clinical Laboratory Analysis.

Related Links:
Chinese PLA General Hospital
Becton, Dickinson and Company
Merck-Millipore
bioMérieux
Luminex Corporation
Siemens
Roche



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image Credit: Adobe Stock

Companion Diagnostics Expand HER2 Testing in Metastatic Gastroesophageal Cancer

Gastroesophageal adenocarcinoma comprises a group of aggressive cancers that are often diagnosed at an advanced stage and carry poor prognoses. Gastric and esophageal cancers rank among the leading causes... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.